ES2151489T3 - Procedimiento y composicion para el tratamiento de trastornos relacionados con herpes. - Google Patents

Procedimiento y composicion para el tratamiento de trastornos relacionados con herpes.

Info

Publication number
ES2151489T3
ES2151489T3 ES92911249T ES92911249T ES2151489T3 ES 2151489 T3 ES2151489 T3 ES 2151489T3 ES 92911249 T ES92911249 T ES 92911249T ES 92911249 T ES92911249 T ES 92911249T ES 2151489 T3 ES2151489 T3 ES 2151489T3
Authority
ES
Spain
Prior art keywords
herpes
treatment
composition
procedure
related disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92911249T
Other languages
English (en)
Inventor
Ellis L Kline
Walter W Mcalhaney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Molecular Rx Inc
Original Assignee
Molecular Rx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Rx Inc filed Critical Molecular Rx Inc
Application granted granted Critical
Publication of ES2151489T3 publication Critical patent/ES2151489T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE DESCRIBE UN METODO Y COMPOSICION PARA TRATAMIENTO DE DOLENCIAS RELACIONADAS CON HERPES. LA INVENCION COMPRENDE LA ADMINISTRACION DE UN BAJO NIVEL DE PROTEINA NEURAMINIDASA O UN DERIVADO DE LA MISMA. EL METODO ES PARTICULARMENTE EFECTIVO EN EL TRATAMIENTO DE DOLENCIAS RELACIONADAS CON HERPES, TAL COMO ULCERAS FRIAS, LESIONES DE HERPES EN GENERAL Y SINDROME DE FATIGA CRONICA.
ES92911249T 1991-04-09 1992-04-06 Procedimiento y composicion para el tratamiento de trastornos relacionados con herpes. Expired - Lifetime ES2151489T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68207191A 1991-04-09 1991-04-09
US86054692A 1992-04-03 1992-04-03

Publications (1)

Publication Number Publication Date
ES2151489T3 true ES2151489T3 (es) 2001-01-01

Family

ID=27102809

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92911249T Expired - Lifetime ES2151489T3 (es) 1991-04-09 1992-04-06 Procedimiento y composicion para el tratamiento de trastornos relacionados con herpes.

Country Status (15)

Country Link
US (2) US5558863A (es)
EP (1) EP0579765B1 (es)
JP (1) JP3266254B2 (es)
AT (1) ATE196424T1 (es)
AU (1) AU662152B2 (es)
BR (1) BR9205877A (es)
CA (1) CA2108135C (es)
DE (1) DE69231465T2 (es)
DK (1) DK0579765T3 (es)
ES (1) ES2151489T3 (es)
GR (1) GR3035004T3 (es)
IE (1) IE921141A1 (es)
IL (1) IL101540A (es)
NO (1) NO313489B1 (es)
WO (1) WO1992018158A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001076621A2 (en) * 2000-04-07 2001-10-18 Kline Ellis L Methods and compositions for treating neoplasms
JP5414366B2 (ja) * 2009-05-29 2014-02-12 独立行政法人科学技術振興機構 疼痛治療剤
AU2013323472B2 (en) * 2012-09-28 2018-07-05 Ellis KLINE Glycosidase regimen for treatment of infectious disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI790483A (fi) * 1978-02-16 1979-08-17 Science Union & Cie Foerfarande foer framstaellning av ett enzym av bakteriellt ursprung och farmaceutiska kompositioner innehaollande detsamma
JPS575916A (en) * 1980-06-13 1982-01-12 Teijin Ltd Polyester fiber with soft touch and production of knitted and woven fabrics therefrom

Also Published As

Publication number Publication date
DK0579765T3 (da) 2000-10-09
AU662152B2 (en) 1995-08-24
WO1992018158A1 (en) 1992-10-29
DE69231465T2 (de) 2001-04-19
NO933628L (no) 1993-12-08
EP0579765A4 (en) 1994-08-24
ATE196424T1 (de) 2000-10-15
IL101540A0 (en) 1992-12-30
IE921141A1 (en) 1992-10-21
DE69231465D1 (de) 2000-10-26
JPH06506698A (ja) 1994-07-28
CA2108135C (en) 2008-03-11
AU1926492A (en) 1992-11-17
GR3035004T3 (en) 2001-03-30
EP0579765B1 (en) 2000-09-20
US5736133A (en) 1998-04-07
IL101540A (en) 1996-10-31
JP3266254B2 (ja) 2002-03-18
EP0579765A1 (en) 1994-01-26
CA2108135A1 (en) 1992-10-10
NO313489B1 (no) 2002-10-14
NO933628D0 (no) 1993-10-08
US5558863A (en) 1996-09-24
BR9205877A (pt) 1994-09-27

Similar Documents

Publication Publication Date Title
ES2191152T3 (es) Terapia combinada para el tratamiento de psicosis.
PT814831E (pt) Medicamentos para o tratamento de doencas autoimunitarias utilizando o interferao tau
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
EP1007556A4 (en) TROPONIN SUB-UNITS AND FRAGMENTS FOR USE AS INHIBITORS OF ANGIOGENESIS
BR9907995A (pt) Métodos imunológicos para modular miostatina em sujeitos vertebrados
AR030068A1 (es) Composiciones farmaceuticas para el tratamiento de condiciones dolorosas, inflamatorias y ulcerosas de superficies epiteliales humedas como por ejemplo mucositis, estomatitis y sindrome de behcet
NO990522L (no) Anvendelse av <beta>-ark mimetika som protease- og kinaseinhibatorer av transkripsjonsfaktorer
AR008799A1 (es) Composicion de vacuna para prevenir o tratar el paludismo; uso de dicha composicion para elaborar medicamentos y metodo para dicha profilaxis y dichotratamiento
ES2083597T3 (es) Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
ES2167401T3 (es) Uso de ascorbil-gamma-linolenato o un ascorbil-dihomo-gamma-linolenato para el tratamiento de asma, cancer, enfermedades cardiovasculares y anti-inflamatorias.
ES2087160T3 (es) Composiciones y procedimiento para el tratamiento de trastornos dolorosos, inflamatorios o alergicos.
DK0457849T3 (da) Klæbemiddel til elektrotransport
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
ES2174337T3 (es) Uso topico de los agonistas opioides kappa para el tratamiento del dolor ocular.
ES2192190T3 (es) Fragmentos proteicos tensioactivos pulmonares.
SE9603725D0 (sv) New teatment
ITRM960364A0 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
ES2192764T3 (es) Mimeticos de lamina beta y metodos relacionados con el uso de los mismos.
ES2151489T3 (es) Procedimiento y composicion para el tratamiento de trastornos relacionados con herpes.
AR015956A1 (es) Composiciones de citoquinas oromucosales y usos de las mismas
ES2135254T3 (es) Procedimiento para la degradacion de quinolonas y naftiridonas.
SE8403659L (sv) Synergistiska farmaceutiska kompositioner
GR3034414T3 (en) Pharmaceutical compositions comprising calcitonin.
ES2147796T3 (es) Composicion para el tratamiento o la prevencion del herpes.
ES2188742T3 (es) Trapidil para uso en la terapia de cuadros patologicos influenciables por la inmunomodulacion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 579765

Country of ref document: ES